3 completed, 3 recruiting, 3 unknown, 2 active not recruiting. 5 Phase 1, 4 Not applicable, 2 Phase 2.
Follow ALL, Childhood: new trials by email Literature Review of ALL, Childhood trials Research Report on ALL, Childhood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL NOURISH-ALL - ALL, Childhood, Behavior, Health | Not applicable | Not yet recruiting | University of Kansas Medical Center | 20 | 2026-09-01 | 2026-07-08 |
| CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies Fludarabine, Cyclophosphamide, CD70-CAR T cell infusion (Autologous) - Hematologic Malignancy, ALL, Childhood | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 18 | 2024-10-16 | 2026-01-23 |
| Retun-to-school Adaptation Program for Children With Cancer training and counselling, Interview - Childhood Cancer, ALL, Childhood | Not applicable | Completed | Gazi University | 20 | 2023-05-30 | 2025-09-29 |
| Childhood Cancer Survivors' Affective Response to Exercise Affective Response to Exercise - ALL, Childhood, Acute Lymphoblastic Leukemia | Active not recruiting | St. Jude Children's Research Hospital | 125 | 2023-03-22 | 2026-08-28 | |
| Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia ALL, Childhood, Pediatric Cancer | Recruiting | University of Geneva, Switzerland | 556 | 2022-12-01 | 2026-01-15 | |
| Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies KUR-502 - NHL, Relapsed, Adult, B-cell Lymphoma | Phase 1 | Unknown | Athenex, Inc. | 36 | 2022-10-01 | 2023-05-18 |
| ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT Blinatumomab - ALL, Childhood, Minimal Residual Disease | Phase 2 | Terminated | Prof. Christina Peters | 3 | 2020-12-17 | 2024-01-16 |
| Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia Ruxolitinib, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, ALL, Childhood | Phase 1 | Recruiting | University of Chicago | 15 | 2019-05-28 | 2026-06-29 |
| Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy ALL, Childhood | Unknown | Assiut University | 50 | 2019-04-01 | 2019-03-26 | |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Ixazomib, Vincristine, Dexamethasone - ALL, Childhood, Lymphoblastic Lymphoma, Childhood | Phase 1 / Phase 2 | Active not recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 24 | 2019-02-12 | 2025-06-17 |
| Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch Leukemia, Lymphoblastic, Acute, ALL, Childhood | Completed | National Cancer Institute (NCI) | 150 | 2018-08-02 | 2022-06-01 | |
| Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids Intraocular pressure measurment - ALL, Childhood, Steroid-Induced Glaucoma | Not applicable | Unknown | Rabin Medical Center | 100 | 2018-07-09 | 2021-10-22 |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy Marqibo - ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Completed | Therapeutic Advances in Childhood Leukemia Consortium | 29 | 2017-01-31 | 2025-10-22 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors Methylphenidate, Placebo - ALL, Childhood, Leukemia, Lymphoblastic | Not applicable | Terminated | University of Minnesota | 1 | 2010-05-01 | 2015-03-27 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (14) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Neoplasm, Residual (2) · Neoplasms (2) · Brain Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Drug-Related Side Effects and Adverse Reactions (1) · Genetic Predisposition to Disease (1) · Health Behavior (1) · Hematologic Neoplasms (1) · Leukemia, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Recurrence (1)
Hematologic Diseases (14) · Hemic and Lymphatic Diseases (14) · Immune System Diseases (14) · Immunoproliferative Disorders (14) · Leukemia (14) · Leukemia, Lymphoid (14) · Lymphatic Diseases (14) · Lymphoproliferative Disorders (14) · Neoplasms by Histologic Type (14) · Neoplasms (12) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Disease Attributes (2) · Leukemia, Myeloid (2) · Neoplasms by Site (2)
Vincristine (3) · Cyclophosphamide (2) · Cytarabine (2) · Dexamethasone (2) · Doxorubicin (2) · Methotrexate (2) · Administration, Intravenous (1) · Asparaginase (1) · Counseling (1) · Hydrocortisone (1) · Interviews as Topic (1) · Leucovorin (1) · Mercaptopurine (1) · Mesna (1) · Methylphenidate (1)
St. Jude Children's Research Hospital (2) · Therapeutic Advances in Childhood Leukemia Consortium (2) · Assiut University (1) · Athenex, Inc. (1) · Gazi University (1) · National Cancer Institute (NCI) (1) · Prof. Christina Peters (1) · Rabin Medical Center (1) · University of Chicago (1) · University of Geneva, Switzerland (1) · University of Kansas Medical Center (1) · University of Minnesota (1)
United States (9) · Australia (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · India (1) · Israel (1) · Italy (1) · Norway (1) · Poland (1) · Slovakia (1) · Spain (1)
Alicia Kunin-Batson, Ph.D. (1) · Carlos Ramos, MD (1) · Carolyn Bates, PhD (1) · Christina Peters, MD (1) · Deo Srivastava, PhD (1) · Gizem Cakir, PhD (1) · Keith August, MD (1) · Kevin Krull, PhD (1) · Kirsten Ness, PhD (1) · Leslie Robinson, PhD (1) · Lisa Jacola, PhD, ABPP-CN2 (1) · Melissa Hudson, MD (1) · Nirali N Shah, M.D. (1)
PMID 32481505, PMID 39937083, PMID 42376206
K08CA279877 (1)